Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NOS2 | P35228 | 2/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | GLI1 | P08151 | 1/20 | 0.32 |
| ▸ | PRCP | P42785 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 2/20 | 0.30 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.30 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL17199761 | 0.92 | ALOX15 (0.41) | ALOX15BLMPMP22KMT2ANOS2 | |
| SCHEMBL2201568 | 0.89 | NOS2 (0.33) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL30716624 | 0.89 | QARS1 (0.40) | BLMNOS2NOS3NOS1DPP7 | |
| Threonine SCHEMBL4289282 | 0.89 | KMT2A (0.35) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL2537702 | 0.86 | NOS2 (0.39) | NOS2NOS3NOS1DPP7GLI1 | |
| SCHEMBL11559576 | 0.85 | NOS2 (0.36) | KMT2ANOS2NOS3NOS1DPP7 | |
| Proline SCHEMBL3105891 | 0.84 | KMT2A (0.38) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL787736 | 0.83 | DPP7 (0.35) | NOS2NOS3NOS1DPP7PRCP | |
| SCHEMBL285831 | 0.82 | NOS2 (0.37) | NOS2NOS3NOS1DPP7GLI1 | |
| SCHEMBL1537264 | 0.82 | DPP7 (0.40) | NOS2NOS3NOS1DPP7PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024112863-A1 | COMPOSITIONS AND METHODS TO INCREASE FEED EFFICIENCY IN ANIMALS | CHURCH & DWIGHT CO., INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| US-20240058246-A1 | LIPO-AMINO ACID ALKYL ESTERS AS SPF BOOSTERS | PRODOTTI GIANNI S.R.L. (IT) | 2024-02-22 | — | — | US | disclosed |
| US-11793738-B2 | Lipo-amino acid alkyl esters as SPF boosters | PRODOTTI GIANNI S.R.L. (IT) | 2023-10-24 | — | — | US | disclosed |
| EP-4011357-A1 | LIPO-AMINO ACID ALKYL ESTERS AS SPF BOOSTERS | Prodotti Gianni S.r.l. (IT) | 2022-06-15 | — | — | EP | disclosed |
| US-20220175645-A1 | LIPO-AMINO ACID ALKYL ESTERS AS SPF BOOSTERS | PRODOTTI GIANNI S.R.L. (IT) | 2022-06-09 | — | — | US | disclosed |
| EP-1716238-B1 | METHOD FOR MODIFYING GENE EXPRESSION OF A PHYTOPATHOGENIC FUNGUS | BAYER SAS (FR) | 2017-12-06 | — | — | EP | disclosed |
| EP-2464248-B1 | COMPOSITION INCLUDING AN UNSAPONIFIABLE FRACTION | EXPANSCIENCE LAB (FR) | 2017-11-08 | — | — | EP | disclosed |
| EP-2464248-A2 | COMPOSITION INCLUDING AN UNSAPONIFIABLE FRACTION | Laboratoires Expanscience (FR) | 2012-06-20 | — | — | EP | disclosed |
| WO-2011018501-A2 | COMPOSITION INCLUDING AN UNSAPONIFIABLE FRACTION | LABORATOIRES EXPANSCIENCE (FR) | 2011-02-17 | — | — | WO | disclosed |
| US-7741531-B2 | Method for modifying gene expression of a phytopathogenic fungus | BAYER S.A.S. (FR) | 2010-06-22 | — | — | US | disclosed |
| US-6943011-B2 | Localization and characterization of the Wilms' tumor gene | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2005-09-13 | — | — | US | disclosed |
| WO-2005071091-A1 | METHOD FOR MODIFYING GENE EXPRESSION OF A PHYTOPATHOGENIC FUNGUS | BAYER CROPSCIENCE SA (FR) | 2005-08-04 | — | — | WO | disclosed |
| US-20020128196-A1 | Localization and characterization of the Wilms' tumor gene | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-09-12 | — | — | US | disclosed |
| US-20020082394-A1 | Localization and characterization of the wilms' tumor gene | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2002-06-27 | — | — | US | disclosed |
| US-6316599-B1 | PREFERENTIAL ANTIBODY FOR USE IN THE DIAGNOSIS AND DETECTION AND TREATMENT OF TUMORS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-11-13 | — | — | US | disclosed |
| EP-0995271-A1 | BIOLOGICAL DATA | Hexagen Technology Limited (GB) | 2000-04-26 | — | — | EP | disclosed |
| WO-1999001940-A1 | BIOLOGICAL DATA | HEXAGEN TECHNOLOGY LIMITED (GB) | 1999-01-14 | — | — | WO | disclosed |
| US-5726288-A | DNA WITH NUCLEIC ACID SEQUENCE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1998-03-10 | — | — | US | disclosed |
| EP-0546108-A4 | PRO-DRUGS FOR CCK ANTAGONISTS | — | 1993-09-22 | — | — | EP | disclosed |
| EP-0546108-A1 | PRO-DRUGS FOR CCK ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1993-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793738-B2 | Lipo-amino acid alkyl esters as SPF boosters | SLC43A1, CUTA, AADAT | ALOX15 51/4885BLM 1366/4885PMP22 3647/4885 |
| US-20220175645-A1 | LIPO-AMINO ACID ALKYL ESTERS AS SPF BOOSTERS | SLC43A1, CUTA, AADAT | ALOX15 51/4885BLM 1366/4885PMP22 3647/4885 |
| US-20240058246-A1 | LIPO-AMINO ACID ALKYL ESTERS AS SPF BOOSTERS | SLC43A1, CUTA, AADAT | ALOX15 51/4885BLM 1366/4885PMP22 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.